The policy provides coverage for SI joint denervation for patients diagnosed with chronic sacroiliac joint pain. The new policy went into effect on July 28.
SInergy is a minimally invasive treatment that targets pain generating nerves in the low back and buttock region responsible for sacroiliac joint pain.
More Articles on Pain Management:
Miami’s Center for Regenerative Medicine Introduces Genorthix System for Joint Health
Hollywog Receives FDA Clearance for Back Pain Device
World Congress on Pain to Feature Neuropathic & Cancer Pain
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
